The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease

References

• Vanier MT. Complex lipid trafficking in Niemann-Pick disease type C. J Inherit Metab Dis 2015;38:187-99
   PubMed Web of Science ®Google Scholar
• Vanier MT, Millat G. Niemann-Pick disease type C. Clin Genet 2003;64:269-81
   PubMed Web of Science ®Google Scholar
• te Vruchte D, Lloyd-Evans E, Veldman RJ, et al. Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport. J Biol Chem 2004;279:26167-75
   PubMed Web of Science ®Google Scholar
• Lloyd-Evans E, Platt FM. Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease. Traffic 2010;11:419-28
   PubMed Web of Science ®Google Scholar
• Mengel E, Klünemann HH, Lourenco CM, et al. Niemann-Pick disease type C symptomatology: an expert-based clinical description. Orphanet J Rare Dis 2013;8:166
   PubMed Web of Science ®Google Scholar
• Jahnova H, Dvorakova L, Vlaskova H, et al. Observational, retrospective study of a large cohort of patients with Niemann-Pick disease type C in the Czech Republic: a surprisingly stable diagnostic rate spanning almost 40 years. Orphanet J Rare Dis 2014;9:140
   PubMed Web of Science ®Google Scholar
• Walterfang M, Bonnot O, Mocellin R, et al. The neuropsychiatry of inborn errors of metabolism. J Inherit Metab Dis 2013;36:687-702
   PubMed Web of Science ®Google Scholar
• Vanier MT. Niemann-Pick disease type C. Orphanet J Rare Dis 2010;5:16
   PubMed Web of Science ®Google Scholar
• Wassif CA, Cross JL, Iben J, et al. High incidence of unrecognized visceral/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets. Genet Med 2016;18:41-8
   PubMed Web of Science ®Google Scholar
• Patterson MC, Hendriksz CJ, Walterfang M, et al. Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol Genet Metab 2012;106:330-44
   PubMed Web of Science ®Google Scholar
• Wraith JE, Baumgartner MR, Bembi B, et al. Recommendations on the diagnosis and management of Niemann-Pick disease type C. Mol Genet Metab 2009;98:152-65
   PubMed Web of Science ®Google Scholar
• Imrie J, Dasgupta S, Besley GT, et al. The natural history of Niemann-Pick disease type C in the UK. J Inherit Metab Dis 2007;30:51-9
   PubMed Web of Science ®Google Scholar
• Patterson MC, Mengel E, Wijburg FA, et al. Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis 2013;8:12
   PubMed Web of Science ®Google Scholar
• Iturriaga C, Pineda M, Fernandez-Valero EM, et al. Niemann-Pick C disease in Spain: clinical spectrum and development of a disability scale. J Neurol Sci 2006;249:1-6
   PubMed Web of Science ®Google Scholar
• Zarowski M, Steinborn B, Gurda B, et al. Treatment of cataplexy in Niemann-Pick disease type C with the use of miglustat. Eur J Paediatr Neurol 2011;15:84-7
   PubMed Web of Science ®Google Scholar
• Imrie J, Wraith JE. Isolated splenomegaly as the presenting feature of Niemann-Pick disease type C. Arch Dis Child 2001;84:427-9
   PubMed Web of Science ®Google Scholar
• Kelly DA, Portmann B, Mowat AP, et al. Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J Pediatr 1993;123:242-7
   PubMed Web of Science ®Google Scholar
• Bonnot O, Klünemann HH, Velten C, et al. Systematic review of psychiatric signs associated with Niemann Pick disease type C and analysis of symptom groups. J Clin Psych 2016;submitted
   Google Scholar
• Maubert A, Hanon C, Sedel F. Psychiatric disorders in adult form of Niemann-Pick disease type C. L’Encephale 2016;42:208-13
   PubMed Web of Science ®Google Scholar
• Synofzik M, Harmuth F, Stampfer M, et al. NPC1 is enriched in unexplained early onset ataxia: a targeted high-throughput screening. J Neurol 2015;262:2557-63
   PubMed Web of Science ®Google Scholar
• Vanier MT, Gissen P, Bauer P, et al. Diagnostic tests for Niemann-Pick disease type C (NP-C): A critical review. Mol Genet Metab 2016;118:244-54
   PubMed Web of Science ®Google Scholar
• Zech M, Nubling G, Castrop F, et al. Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders. PLoS One 2013;8:e82879
   PubMed Web of Science ®Google Scholar
• Alavi A, Nafissi S, Shamshiri H, et al. Identification of mutation in NPC2 by exome sequencing results in diagnosis of Niemann-Pick disease type C. Mol Genet Metab 2013;110:139-44
   PubMed Web of Science ®Google Scholar
• Herbst SM, Schirmer S, Posovszky C, et al. Taking the next step forward - Diagnosing inherited infantile cholestatic disorders with next generation sequencing. Molec Cell Probes 2015;29:291-8
   PubMed Web of Science ®Google Scholar
• Porter FD, Scherrer DE, Lanier MH, et al. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med 2010;2:56ra81
   PubMed Web of Science ®Google Scholar
• Jiang X, Sidhu R, Porter FD, et al. A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. J Lipid Res 2011;52:1435-45
   PubMed Web of Science ®Google Scholar
• Welford RW, Garzotti M, Marques Lourenco C, et al. Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study. PLoS One 2014;9:e114669
   PubMed Web of Science ®Google Scholar
• Giese AK, Mascher H, Grittner U, et al. A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease. Orphanet J Rare Dis 2015;10:78
   PubMed Web of Science ®Google Scholar
• Mazzacuva F, Mills P, Mills K, et al. Identification of novel bile acids as biomarkers for the early diagnosis of Niemann-Pick C disease. FEBS Lett 2016;590:1651-62
   PubMed Web of Science ®Google Scholar
• Jiang X, Sidhu R, Mydock-McGrane L, et al. Development of a bile acid-based newborn screen for Niemann-Pick disease type C. Sci Transl Med 2016;8:337ra63
   PubMed Web of Science ®Google Scholar
• Synofzik M, Fleszar Z, Schols L, et al. Identifying Niemann-Pick type C in early-onset ataxia: two quick clinical screening tools. J Neurol 2016;263:1911-18
   PubMed Web of Science ®Google Scholar
• Wijburg FA, Sedel F, Pineda M, et al. Development of a suspicion index to aid diagnosis of Niemann-Pick disease type C. Neurology 2012;78:1560-7
   PubMed Web of Science ®Google Scholar
• Hendriksz CJ, Pineda M, Fahey M, et al. The Niemann-Pick disease Type C suspicion index: development of a revised tool with improved predictive ability. J Inherit Metab Dis 2014;37:Abstract p. 372
   Google Scholar
• Sheth J, Mistri M, Sheth F, et al. Burden of lysosomal storage disorders in India: experience of 387 affected children from a single diagnostic facility. JIMD Rep 2014;12:51-63
   PubMedGoogle Scholar
• Corry PC. Consanguinity and prevalence patterns of inherited disease in the UK Pakistani community. Hum Heredity 2014;77:207-16
   PubMed Web of Science ®Google Scholar
• Jaouad IC, Elalaoui SC, Sbiti A, et al. Consanguineous marriages in Morocco and the consequence for the incidence of autosomal recessive disorders. J Biosocial Sci 2009;41:575-81
   PubMed Web of Science ®Google Scholar
• Tuncbilek E. Clinical outcomes of consanguineous marriages in Turkey. Turkish J Pediatr 2001;43:277-9
   PubMed Web of Science ®Google Scholar
• Bauer P, Knoblich R, Bauer C, et al. NPC1: Complete genomic sequence, mutation analysis, and characterization of haplotypes. Hum Mutat 2002;19:30-8
   PubMed Web of Science ®Google Scholar
• Millat G, Chikh K, Naureckiene S, et al. Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group. Am J Hum Genet 2001;69:1013-21
   PubMed Web of Science ®Google Scholar
• Fernandez-Valero EM, Ballart A, Iturriaga C, et al. Identification of 25 new mutations in 40 unrelated Spanish Niemann-Pick type C patients: genotype-phenotype correlations. Clin Genet 2005;68:245-54
   PubMed Web of Science ®Google Scholar
• Cervera-Gaviria M, Alcantara-Ortigoza MA, Gonzalez-Del Angel A, et al. An uncommon inheritance pattern in Niemann-Pick disease type C: identification of probable paternal germline mosaicism in a Mexican family. BMC Neurol 2016;16:147
   PubMed Web of Science ®Google Scholar
• Imrie J, Heptinstall L, Knight S, et al. Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database. BMC Neurol 2015;15:257
   PubMed Web of Science ®Google Scholar
• Moammar H, Cheriyan G, Mathew R, et al. Incidence and patterns of inborn errors of metabolism in the Eastern Province of Saudi Arabia, 1983–2008. Ann Saudi Med 2010;30:271-7
   PubMed Web of Science ®Google Scholar
• Al-Jasmi FA, Tawfig N, Berniah A, et al. Prevalence and novel mutations of lysosomal storage disorders in United Arab Emirates: LSD in UAE. JIMD Rep 2013;10:1-9
   PubMedGoogle Scholar
• Elmonem MA, Mahmoud IG, Mehaney DA, et al. Lysosomal storage disorders in Egyptian children. Indian J Pediatr 2016;83:805-13
   PubMed Web of Science ®Google Scholar
• Akbayram S, Sari N, Akgun C, et al. The frequency of consanguineous marriage in eastern Turkey. Genet Counsel 2009;20:207-14
   PubMed Web of Science ®Google Scholar
• Christopher R, Nalini A. Cerebral lipidoses in patients with progressive neurodegeneration: a study from south India. Commun Genet 2002;5:186-91
   PubMedGoogle Scholar
• Bener A, Hussain R, Teebi AS. Consanguineous marriages and their effect on common diseases in the qatari population. Med Princ Pract 2007;16:262-7
   PubMed Web of Science ®Google Scholar
• Ben Halim N, Hsouna S, Lasram K, et al. Differential impact of consanguineous marriages on autosomal recessive diseases in Tunisia. Am J Hum Biol 2016;28:171-80
   PubMed Web of Science ®Google Scholar
• Millat G, Marcais C, Rafi MA, et al. Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype. Am J Hum Genet 1999;65:1321-9
   PubMed Web of Science ®Google Scholar
• Mavridou I, Cozar M, Douzgou S, et al. Niemann-Pick type C disease: a novel NPC1 mutation segregating in a Greek island. Clin Genet 2014;85:543-7
   PubMed Web of Science ®Google Scholar
• Greer WL, Riddell DC, Gillan TL, et al. The Nova Scotia (type D) form of Niemann-Pick disease is caused by a G3097–>T transversion in NPC1. Am J Hum Genet 1998;63:52-4
   PubMed Web of Science ®Google Scholar
• Winsor EJ, Welch JP. Genetic and demographic aspects of Nova Scotia Niemann-Pick disease (type D). Am J Hum Genet 1978;30:530-8
   PubMed Web of Science ®Google Scholar
• Alazami AM, Patel N, Shamseldin HE, et al. Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families. Cell Rep 2015;10:148-61
   PubMed Web of Science ®Google Scholar
• Mechtler TP, Metz TF, Muller HG, et al. Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening. J Chromatogr B Analyt Technol Biomed Life Sci 2012;908:9-17
   PubMed Web of Science ®Google Scholar
• Schicks J, Muller Vom Hagen J, Bauer P, et al. Niemann-Pick type C is frequent in adult ataxia with cognitive decline and vertical gaze palsy. Neurology 2013;80:1169-70
   PubMed Web of Science ®Google Scholar
• Garver WS, Francis GA, Jelinek D, et al. The national Niemann-Pick C1 disease database: report of clinical features and health problems. Am J Med Genet A 2007;143A:1204-11
   PubMed Web of Science ®Google Scholar
• Micheli F, Perandones C, Giugni J, et al. Is progressive supranuclear palsy part of the phenotypic spectrum of Niemann-Pick disease type C? Neurology 2013;80:P04.158
   Web of Science ®Google Scholar
• Anheim M, Lagha-Boukbiza O, Fleury-Lesaunier MC, et al. Heterogeneity and frequency of movement disorders in juvenile and adult-onset Niemann-Pick C disease. J Neurol 2014;261:174-9
   PubMed Web of Science ®Google Scholar
• Anheim M, Tranchant C, Koenig M. The autosomal recessive cerebellar ataxias. N Engl J Med 2012;366:636-46
   PubMed Web of Science ®Google Scholar
• Sedel F, Saudubray JM, Roze E, et al. Movement disorders and inborn errors of metabolism in adults: a diagnostic approach. J Inherit Metab Dis 2008;31:308-18
   PubMed Web of Science ®Google Scholar
• Braga Neto P, Pedroso JL, Kuo SH, et al. Current concepts in the treatment of hereditary ataxias. Arq Neuropsiquiatr 2016;74:244-52
   PubMed Web of Science ®Google Scholar
• Koens LH, Kuiper A, Coenen MA, et al. Ataxia, dystonia and myoclonus in adult patients with Niemann-Pick type C. Orphanet J Rare Dis 2016;11:121
   PubMed Web of Science ®Google Scholar
• Mallaret M, Renaud M, Redin C, et al. Validation of a clinical practice-based algorithm for the diagnosis of autosomal recessive cerebellar ataxias based on NGS identified cases. J Neurol 2016;263:1314-22
   PubMed Web of Science ®Google Scholar
• Anheim M, Fleury M, Monga B, et al. Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics 2010;11:1-12
   PubMed Web of Science ®Google Scholar
• Tripathi M, Tang CC, Feigin A, et al. Automated differential diagnosis of early parkinsonism using metabolic brain networks: a validation study. J Nucl Med 2016;57:60-6
   PubMed Web of Science ®Google Scholar
• Mancuso M, Orsucci D, Siciliano G, et al. The genetics of ataxia: through the labyrinth of the Minotaur, looking for Ariadne’s thread. J Neurol 2014;261(Suppl 2):S528-S41
   PubMed Web of Science ®Google Scholar
• Harmuth F, Synofzik M, Stampfer M, et al. NPC1/2 mutations are significantly enriched in a cohort of unexplained early onset ataxia [abstract P-ClinG-097]. Med Genet 2016;1:153
   Google Scholar
• Sevin M, Lesca G, Baumann N, et al. The adult form of Niemann-Pick disease type C. Brain 2007;130:120-33
   PubMed Web of Science ®Google Scholar
• de Koning TJ, Tijssen MA. Movement disorders in 2014. Genetic advances spark a revolution in dystonia phenotyping. Nat Rev Neurol 2015;11:78-9
   PubMed Web of Science ®Google Scholar
• Hubsch C, Roze E, Popa T, et al. Defective cerebellar control of cortical plasticity in writer’s cramp. Brain 2013;136:2050-62
   PubMed Web of Science ®Google Scholar
• Bonnot O, Herrera PM, Tordjman S, et al. Secondary psychosis induced by metabolic disorders. Front Neurosci 2015;9:177
   PubMed Web of Science ®Google Scholar
• Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013;28:863-73
   PubMed Web of Science ®Google Scholar
• Bonnot O, Gama CS, Mengel E, et al. Psychiatric and neurological symptoms in patients with Niemann-Pick disease type C (NP-C): findings from the International NPC Registry. J Inherit Metab Dis 2016;39(Suppl 1):S62-S3
   Google Scholar
• Crespia J, Bråthena G, Quist-Paulsenb P, et al. Facial dystonia with facial grimacing and vertical gaze palsy with “round the houses” sign in a 29-year-old woman. Neuro-ophthalmology 2016;40:37-41
   Web of Science ®Google Scholar
• Bauer P, Balding DJ, Klünemann HH, et al. Genetic screening for Niemann-Pick disease type C in adults with neurological and psychiatric symptoms: findings from the ZOOM study. Hum Mol Genet 2013;22:4349-56
   PubMed Web of Science ®Google Scholar
• Nunn K, Williams K, Ouvrier R. The Australian childhood dementia study. Eur Child Adolesc Psychiatry 2002;11:63-70
   PubMed Web of Science ®Google Scholar
• Cupidi C, Frangipane F, Gallo M, et al. Role of Niemann-Pick type C disease mutations in dementia. J Alzheimers Dis 2016;55:1249-59
   Web of Science ®Google Scholar
• Saito Y, Suzuki K, Nanba E, et al. Niemann-Pick type C disease: accelerated neurofibrillary tangle formation and amyloid beta deposition associated with apolipoprotein E epsilon 4 homozygosity. Ann Neurol 2002;52:351-5
   PubMed Web of Science ®Google Scholar
• Saito Y, Suzuki K, Hulette CM, et al. Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease. J Neuropathol Exp Neurol 2004;63:323-8
   PubMed Web of Science ®Google Scholar
• Love S, Bridges LR, Case CP. Neurofibrillary tangles in Niemann-Pick disease type C. Brain 1995;118(Pt 1):119-29
   PubMed Web of Science ®Google Scholar
• Contreras PS, Gonzalez-Zuniga M, Gonzalez-Hodar L, et al. Neuronal gene repression in Niemann-Pick type C models is mediated by the c-Abl/HDAC2 signaling pathway. Biochim Biophys Acta 2016;1859:269-79
   PubMed Web of Science ®Google Scholar
• Yanez MJ, Belbin O, Estrada LD, et al. c-Abl links APP-BACE1 interaction promoting APP amyloidogenic processing in Niemann-Pick type C disease. Biochim Biophys Acta 2016;1862:2158-67
   PubMed Web of Science ®Google Scholar
• Reddy JV, Ganley IG, Pfeffer SR. Clues to neuro-degeneration in Niemann-Pick type C disease from global gene expression profiling. PLoS ONE 2006;1:e19
   PubMed Web of Science ®Google Scholar
• Mattsson N, Zetterberg H, Bianconi S, et al. Gamma-secretase-dependent amyloid-beta is increased in Niemann-Pick type C: a cross-sectional study. Neurology 2011;76:366-72
   PubMed Web of Science ®Google Scholar
• Fu R, Yanjanin NM, Elrick MJ, et al. Apolipoprotein E genotype and neurological disease onset in Niemann-Pick disease, type C1. Am J Med Genet A 2012;158A:2775-80
   PubMed Web of Science ®Google Scholar
• Chua CC, Lim ML, Wong BS. Altered apolipoprotein E glycosylation is associated with Abeta(42) accumulation in an animal model of Niemann-Pick Type C disease. J Neurochem 2010;112:1619-26
   PubMed Web of Science ®Google Scholar
• Imrie J, Vijayaraghaven S, Whitehouse C, et al. Niemann-Pick disease type C in adults. J Inherit Metab Dis 2002;25:491-500
   PubMed Web of Science ®Google Scholar
• Klarner B, Klünemann HH, Lurding R, et al. Neuropsychological profile of adult patients with Niemann-Pick C1 (NPC1) mutations. J Inherit Metab Dis 2007;30:60-7
   PubMed Web of Science ®Google Scholar
• Abela L, Plecko B, Palla A, et al. Early co-occurrence of a neurologic-psychiatric disease pattern in Niemann-Pick type C disease: a retrospective Swiss cohort study. Orphanet J Rare Dis 2014;9:176
   PubMed Web of Science ®Google Scholar
• Webber D, Klünemann HH. Psychiatric manifestations of Niemann-Pick disease. J Inherit Metab Dis 2011;4:25-31
   Google Scholar
• Staretz-Chacham O, Choi JH, Wakabayashi K, et al. Psychiatric and behavioral manifestations of lysosomal storage disorders. Am J Med Genet B Neuropsychiatr Genet 2010;153B:1253-65
   PubMed Web of Science ®Google Scholar
• Josephs KA, Van Gerpen MW, Van Gerpen JA. Adult onset Niemann-Pick disease type C presenting with psychosis. J Neurol Neurosurg Psychiatry 2003;74:528-9
   PubMed Web of Science ®Google Scholar
• Stampfer M, Theiss S, Amraoui Y, et al. Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicators. Orphanet J Rare Dis 2013;8:35
   PubMed Web of Science ®Google Scholar
• Nia S. Psychiatric signs and symptoms in treatable inborn errors of metabolism. J Neurol 2014;261(Suppl 2):S559-68
   Web of Science ®Google Scholar
• Hulette CM, Earl NL, Anthony DC, et al. Adult onset Niemann-Pick disease type C presenting with dementia and absent organomegaly. Clin Neuropathol 1992;11:293-7
   PubMed Web of Science ®Google Scholar
• Hendriksz CJ, Pineda M, Fahey M, et al. Improving NP-C screening: identification of seven key discriminatory signs and symptoms. J Inherit Metab Dis 2014;37:Abstract p. 371
   Google Scholar
• Chow TW, Miller BL, Boone K, et al. Frontotemporal dementia classification and neuropsychiatry. Neurologist 2002;8:263-9
   PubMed Web of Science ®Google Scholar
• Knopman DS, Petersen RC, Edland SD, et al. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology 2004;62:506-8
   PubMed Web of Science ®Google Scholar
• Laforce R Jr. Behavioral and language variants of frontotemporal dementia: a review of key symptoms. Clin Neurol Neurosurg 2013;115:2405-10
   PubMed Web of Science ®Google Scholar
• McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol 2001;58:1803-9
   PubMed Web of Science ®Google Scholar
• Walterfang M, Fietz M, Fahey M, et al. The neuropsychiatry of Niemann-Pick type C disease in adulthood. J Neuropsychiatry Clin Neurosci 2006;18:158-70
   PubMed Web of Science ®Google Scholar
• Maubert A, Hanon C, Metton JP. Adult onset Niemann-Pick type C disease and psychosis: literature review. L’Encephale 2013;39:315-19
   PubMed Web of Science ®Google Scholar
• Bonnot O. Niemann-Pick disease type C – example of an inborn error of metabolism producing psychiatric manifestations. Eur Psychiatr Rev 2011;4:84-8
   Google Scholar
• Gustafson L, Brun A, Passant U. Frontal lobe degeneration of non-Alzheimer type. Bailliere’s Clin Neurol 1992;1:559-82
   PubMedGoogle Scholar
• Velakoulis D, Walterfang M, Mocellin R, et al. Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases. Br J Psychiatry 2009;194:298-305
   PubMed Web of Science ®Google Scholar
• Sjogren M, Gustafson L, Wikkelso C, et al. Frontotemporal dementia can be distinguished from Alzheimer’s disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio. Dement Geriatr Cogn Disord 2000;11:275-85
   PubMed Web of Science ®Google Scholar
• Klünemann HH, Santosh PJ, Sedel F. Treatable metabolic psychoses that go undetected: what Niemann-Pick type C can teach us. Int J Psychiatry Clin Pract 2012;16:162-9
   PubMed Web of Science ®Google Scholar
• Shulman LM, David NJ, Weiner WJ. Psychosis as the initial manifestation of adult-onset Niemann-Pick disease type C. Neurology 1995;45:1739-43
   PubMed Web of Science ®Google Scholar
• Stone J, Griffiths TD, Rastogi S, et al. Non-Picks frontotemporal dementia imitating schizophrenia in a 22-year-old man. J Neurol 2003;250:369-70
   PubMed Web of Science ®Google Scholar
• Momeni P, Wickremaratchi MM, Bell J, et al. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia. Clin Neurol Neurosurg 2010;112:917-20
   PubMed Web of Science ®Google Scholar
• Gourzis P, Skokou M, Polychronopoulos P, et al. Frontotemporal dementia, manifested as schizophrenia, with decreased heterochromatin on chromosome 1. Case Rep Psychiatry 2012;2012:1-5
   Google Scholar
• Cooper JJ, Ovsiew F. The relationship between schizophrenia and frontotemporal dementia. J Geriatr Psychiatry Neurol 2013;26:131-7
   PubMed Web of Science ®Google Scholar
• Goldman JS, Farmer JM, Wood EM, et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 2005;65:1817-19
   PubMed Web of Science ®Google Scholar
• Le Ber I, Camuzat A, Guillot-Noel L, et al. C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing. J Alzheimers Dis 2013;34:485-99
   PubMed Web of Science ®Google Scholar
• Devenney E, Foxe D, Dobson-Stone C, et al. Clinical heterogeneity of the C9orf72 genetic mutation in frontotemporal dementia. Neurocase 2015;21:535-41
   PubMed Web of Science ®Google Scholar
• Wood H. A hexanucleotide repeat expansion in C9ORF72 links amyotrophic lateral sclerosis and frontotemporal dementia. Nat Rev Neurol 2011;7:595
   PubMedGoogle Scholar
• Mahoney CJ, Beck J, Rohrer JD, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 2012;135:736-50
   PubMed Web of Science ®Google Scholar
• Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442:916-19
   PubMed Web of Science ®Google Scholar
• Ludolph AC, Kassubek J, Landwehrmeyer BG, et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol 2009;16:297-309
   PubMed Web of Science ®Google Scholar
• Ghetti B, Oblak AL, Boeve BF, et al. Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol Appl Neurobiol 2015;41:24-46
   PubMed Web of Science ®Google Scholar
• Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-5
   PubMed Web of Science ®Google Scholar
• Goedert M, Spillantini MG. Pathogenesis of the tauopathies. J Mol Neurosci 2011;45:425-31
   PubMed Web of Science ®Google Scholar
• Arvanitakis Z. Update on frontotemporal dementia. Neurologist 2010;16:16-22
   PubMed Web of Science ®Google Scholar
• Badiola N, Suarez-Calvet M, Lleo A. Tau phosphorylation and aggregation as a therapeutic target in tauopathies. CNS Neurol Disord Drug Targets 2010;9:727-40
   PubMed Web of Science ®Google Scholar
• Baizabal-Carvallo JF, Jankovic J. Parkinsonism, movement disorders and genetics in frontotemporal dementia. Nat Rev Neurol 2016;12:175-85
   PubMed Web of Science ®Google Scholar
• Coleman RJ, Robb SA, Lake BD, et al. The diverse neurological features of Niemann-Pick disease type C: a report of two cases. Mov Disord 1988;3:295-9
   PubMed Web of Science ®Google Scholar
• Nalls MA, Pankratz N, Lill CM, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet 2014;46:989-93
   PubMed Web of Science ®Google Scholar
• Dehay B, Martinez-Vicente M, Caldwell GA, et al. Lysosomal impairment in Parkinson’s disease. Mov Disord 2013;28:725-32
   PubMed Web of Science ®Google Scholar
• Gan-Or Z, Dion PA, Rouleau GA. Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease. Autophagy 2016;11:1443-57
   Web of Science ®Google Scholar
• Alcalay RN, Levy OA, Waters CC, et al. Glucocerebrosidase activity in Parkinson’s disease with and without GBA mutations. Brain 2015;138:2648-58
   PubMed Web of Science ®Google Scholar
• Dagan E, Schlesinger I, Ayoub M, et al. The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews. Parkinsonism Relat Disord 2015;21:1067-71
   PubMed Web of Science ®Google Scholar
• Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson’s disease. N Engl J Med 2009;361:1651-61
   PubMed Web of Science ®Google Scholar
• Gan-Or Z, Giladi N, Rozovski U, et al. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology 2008;70:2277-83
   PubMed Web of Science ®Google Scholar
• Kim J, Sidransky E, Lopez G. Understanding and managing parkinsonism in patients with glucocerebrosidase mutations. Exp Opin Orphan Drugs 2015;3:549-62
   Web of Science ®Google Scholar
• Gan-Or Z, Ozelius LJ, Bar-Shira A, et al. The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease. Neurology 2013;80:1606-10
   PubMed Web of Science ®Google Scholar
• Liu JP, Tang Y, Zhou S, et al. Cholesterol involvement in the pathogenesis of neurodegenerative diseases. Mol Cell Neurosci 2010;43:33-42
   PubMed Web of Science ®Google Scholar
• Chiba Y, Komori H, Takei S, et al. Niemann-Pick disease type C1 predominantly involving the frontotemporal region, with cortical and brainstem Lewy bodies: an autopsy case. Neuropathology 2014;34:49-57
   PubMed Web of Science ®Google Scholar
• Deng H, Xiu X, Jankovic J. Genetic convergence of Parkinson’s disease and lysosomal storage disorders. Mol Neurobiol 2015;51:1554-68
   PubMed Web of Science ®Google Scholar
• Klünemann HH, Nutt JG, Davis MY, et al. Parkinsonism syndrome in heterozygotes for Niemann-Pick C1. J Neurol Sci 2013;335:219-20
   PubMed Web of Science ®Google Scholar
• Josephs KA, Matsumoto JY, Lindor NM. Heterozygous Niemann-Pick disease type C presenting with tremor. Neurology 2004;63:2189-90
   PubMed Web of Science ®Google Scholar
• Houghton DJ, Litvan I. Unraveling progressive supranuclear palsy: from the bedside back to the bench. Parkinsonism Relat Disord 2007;13(Suppl 3):S341-S6
   PubMed Web of Science ®Google Scholar
• Duvoisin RC. Differential diagnosis of PSP. J Neural Transm Suppl 1994;42:51-67
   PubMedGoogle Scholar
• Stamelou M, Hoeglinger GU. Atypical parkinsonism: an update. Curr Opin Neurol 2013;26:401-5
   PubMed Web of Science ®Google Scholar
• Eggink H, Brandsma R, van der Hoeven JH, et al. Teaching video NeuroImages: the “round the houses” sign as a clinical clue for Niemann-Pick disease type C. Neurology 2016;86:e202
   PubMed Web of Science ®Google Scholar
• Godeiro-Junior C, Inaoka RJ, Barbosa MR, et al Mutations in NPC1 in two Brazilian patients with Niemann-Pick disease type C and progressive supranuclear palsy-like presentation. Mov Disord 2006;21:2270-2
   PubMed Web of Science ®Google Scholar
• Lengyel D, Weissert M, Schmid L, et al. Eye movement abnormalities as a sign for the diagnosis in Niemann-Pick disease type C. Klin Monbl Augenheilkd 1999;214:50-2
   PubMed Web of Science ®Google Scholar
• Salsano E, Umeh C, Rufa A, et al. Vertical supranuclear gaze palsy in Niemann-Pick type C disease. Neurol Sci 2012;33:1225-32
   PubMed Web of Science ®Google Scholar
• Strupp M, Kremmyda O, Adamczyk C, et al. Central ocular motor disorders, including gaze palsy and nystagmus. J Neurol 2014;261(Suppl 2):S542-S58
   PubMed Web of Science ®Google Scholar
• Walterfang M, Macfarlane MD, Looi JC, et al. Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann-Pick disease type C. Eur J Neurol 2012;19:462-7
   PubMed Web of Science ®Google Scholar
• Abel LA, Walterfang M, Fietz M, et al. Saccades in adult Niemann-Pick disease type C reflect frontal, brainstem, and biochemical deficits. Neurology 2009;72:1083-6
   PubMed Web of Science ®Google Scholar
• Solomon D, Winkelman AC, Zee DS, et al. Niemann-Pick type C disease in two affected sisters: ocular motor recordings and brain-stem neuropathology. Ann N Y Acad Sci 2005;1039:436-45
   PubMed Web of Science ®Google Scholar
• Abel LA, Walterfang M, Stainer MJ, et al. Longitudinal assessment of reflexive and volitional saccades in Niemann-Pick Type C disease during treatment with miglustat. Orphanet J Rare Dis 2015;10:160
   PubMed Web of Science ®Google Scholar
• Chio A, Borghero G, Restagno G, et al. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain 2012;135:784-93
   PubMed Web of Science ®Google Scholar
• Dickson DW, Kouri N, Murray ME, et al. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J Molec Neurosci 2011;45:384-9
   PubMed Web of Science ®Google Scholar
• Dickson DW, Ahmed Z, Algom AA, et al. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 2010;23:394-400
   PubMed Web of Science ®Google Scholar
• Höglinger G, Stamelou M, Kurz C, et al. MDS-clinical diagnostic criteria for progressive supranuclear palsy (PSP). Presented at the 20th International Conference on Parkinson’s Disease and Movement Disorders; 2016 [Abstract SG 35]. http://www.mdscongress2016.org/Congress-2016-Files/PDFs/LBASGGPTBooklet.pdf. Accessed January 31, 2017
   Google Scholar
• Averbuch-Heller L, Paulson GW, Daroff RB, et al. Whipple’s disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording. J Neurol Neurosurg Psychiatry 1999;66:532-5
   PubMed Web of Science ®Google Scholar
• Marx S, Respondek G, Stamelou M, et al. Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson’s disease. Front Behav Neurosci 2012;6:88
   PubMed Web of Science ®Google Scholar
• Borroni B, Malinverno M, Gardoni F, et al. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology 2008;71:1796-803
   PubMed Web of Science ®Google Scholar
• Borroni B, Gardoni F, Parnetti L, et al. Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol Aging 2009;30:34-40
   PubMed Web of Science ®Google Scholar
• Bonnot O, Klünemann HH, Sedel F, et al. Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review. Orphanet J Rare Dis 2014;9:65
   PubMed Web of Science ®Google Scholar
• Sedel F, Baumann N, Turpin JC, et al. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis 2007;30:631-41
   PubMed Web of Science ®Google Scholar
• Walterfang M, Fietz M, Abel L, et al. Gender dimorphism in siblings with schizophrenia-like psychosis due to Niemann-Pick disease type C. J Inherit Metab Dis 2009;32(Suppl 1):S221-S6
   PubMed Web of Science ®Google Scholar
• Kulhanek J, Albrecht J, Honzik T, et al. Psychiatric manifestation of inborn errors of metabolism. Ces a Slav Psychiat 2015;111:295-305
   Google Scholar
• Atsuta N, Watanabe H, Ito M, et al. Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. J Neurol Sci 2009;276:163-9
   PubMed Web of Science ®Google Scholar
• Murray ME, Kouri N, Lin WL, et al. Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias. Alzheimers Res Ther 2014;6:1
   PubMed Web of Science ®Google Scholar
• Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)—revised report of an EFNS task force. Eur J Neurol 2012;19:360-75
   PubMed Web of Science ®Google Scholar
• Katsumata R, Ishigaki S, Katsuno M, et al. c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis. PLoS One 2012;7:e46185
   PubMed Web of Science ®Google Scholar
• Marin B, Beghi E, Vial C, et al. Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres. Eur J Neurol 2016;23:787-95
   PubMed Web of Science ®Google Scholar
• Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)—revised report of an EFNS task force. Eur J Neurol 2012;19:360-75
   PubMed Web of Science ®Google Scholar
• Okita T, Nodera H, Shibuta Y, et al. Can Awaji ALS criteria provide earlier diagnosis than the revised El Escorial criteria? J Neurol Sci 2011;302:29-32
   PubMed Web of Science ®Google Scholar
• Iodice R, Dubbioso R, Topa A, et al. Electrophysiological characterization of adult-onset Niemann-Pick type C disease. J Neurol Sci 2015;348:262-5
   PubMed Web of Science ®Google Scholar
• Kingwell E, Marriott JJ, Jette N, et al. Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol 2013;13:128
   PubMed Web of Science ®Google Scholar
• Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008;14:1157-74
   PubMed Web of Science ®Google Scholar
• Chen JJ, Carletti F, Young V, et al. MRI differential diagnosis of suspected multiple sclerosis. Clin Radiol 2016;71:815-27
   PubMed Web of Science ®Google Scholar
• Filippi M, Rocca MA, Ciccarelli O, et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 2016;15:292-303
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 2005;58:840-6
   PubMed Web of Science ®Google Scholar
• Costello F. Vision disturbances in multiple sclerosis. Semin Neurol 2016;36:185-95
   PubMed Web of Science ®Google Scholar
• Pflugshaupt T, Geisseler O, Nyffeler T, et al. Cognitive impairment in multiple sclerosis: clinical manifestation, neuroimaging correlates, and treatment. Semin Neurol 2016;36:203-11
   PubMed Web of Science ®Google Scholar
• Korakas N, Tsolaki M. Cognitive impairment in multiple sclerosis: a review of neuropsychological assessments. Cogn Behav Neurol 2016;29:55-67
   PubMed Web of Science ®Google Scholar
• Lee H, Bae JS, Jin HK. Human umbilical cord blood-derived mesenchymal stem cells improve neurological abnormalities of Niemann-Pick type C mouse by modulation of neuroinflammatory condition. J Vet Med Sci 2010;72:709-17
   PubMed Web of Science ®Google Scholar
• Cologna SM, Cluzeau CV, Yanjanin NM, et al. Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1. J Inherit Metab Dis 2014;37:83-92
   PubMed Web of Science ®Google Scholar
• Lopez ME, Klein AD, Hong J, et al. Neuronal and epithelial cell rescue resolves chronic systemic inflammation in the lipid storage disorder Niemann-Pick C. Hum Mol Genet 2012;21:2946-60
   PubMed Web of Science ®Google Scholar
• Swanton JK, Rovira A, Tintore M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007;6:677-86
   PubMed Web of Science ®Google Scholar
• Grau AJ, Brandt T, Weisbrod M, et al. Adult Niemann-Pick disease type C mimicking features of multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:552
   PubMed Web of Science ®Google Scholar
• Yuce A, Gumusa E, Haliloglu G, et al. Niemann-Pick disease type C in the newborn period: Reflections from 10 patients. Molec Genet Metab 2016;117:S14-S124
   Web of Science ®Google Scholar
• Moyer V, Freese DK, Whitington PF, et al. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2004;39:115-28
   PubMed Web of Science ®Google Scholar
• Alobaidy H. Recent advances in the diagnosis and treatment of Niemann-Pick disease type C in children: a guide to early diagnosis for the general pediatrician. Int J Pediatr 2015;2015:1-10
   Google Scholar
• McKiernan PJ. Neonatal cholestasis. Semin Neonatol 2002;7:153-65
   PubMedGoogle Scholar
• Suchy FJ. Neonatal cholestasis. Pediatr Rev 2004;25:388-96
   PubMed Web of Science ®Google Scholar
• Suchy FJS. Approach to the infant with cholestasis. In: Suchy FJS, Sokol RJ, Balistreri WF, editors. Liver disease in children. 3rd edn. Cambridge, UK: Cambridge University Press; 2007. p 179-89
   Google Scholar
• Gotti G, Marseglia A, De Giacomo C, et al. Neonatal jaundice with splenomegaly: not a common pick. Fetal Pediatr Pathol 2016;35:108-11
   PubMed Web of Science ®Google Scholar
• Degtyareva AV, Mikhailova SV, Zakharova EY, et al. Visceral symptoms as a key diagnostic sign for the early infantile form of Niemann-Pick disease type C in a Russian patient: a case report. J Med Case Rep 2016;10:143
   PubMedGoogle Scholar
• Hegarty R, Hadzic N, Gissen P, et al. Inherited metabolic disorders presenting as acute liver failure in newborns and young children: King’s College Hospital experience. Eur J Pediatr 2015;174:1387-92
   PubMed Web of Science ®Google Scholar
• Yerushalmi B, Sokol RJ, Narkewicz MR, et al. Niemann-pick disease type C in neonatal cholestasis at a North American Center. J Pediatr Gastroenterol Nutr 2002;35:44-50
   PubMed Web of Science ®Google Scholar
• Pineda M, Mengel E, Jahnova H, et al. A suspicion index to aid screening of early-onset Niemann-Pick disease type C (NP-C). BMC Pediatr 2016;16:107
   PubMed Web of Science ®Google Scholar
• McKay Bounford K, Ruth N, Yeung A, et al. A gene sequencing assay to determine the frequency of genetic conditions associated with cholestasis in neonates and infants. Manuscript in preparation; 2016
   Google Scholar
• Herbst SM, Hinreiner S, Posovszky C, et al. Next generation sequencing in infantile cholestatic disorders [abstract P-Nomin.-009]. Med Genet 2016:120
   Google Scholar
• Nakamura K, Hattori K, Endo F. Newborn screening for lysosomal storage disorders. Am J Med Genet C, Semin Med Genet 2011;157C:63-71
   PubMed Web of Science ®Google Scholar
• Meikle PJ, Grasby DJ, Dean CJ, et al. Newborn screening for lysosomal storage disorders. Mol Genet Metab 2006;88:307-14
   PubMed Web of Science ®Google Scholar
• Lisi EC, McCandless SE. Newborn screening for lysosomal storage disorders: views of genetic healthcare providers. J Genet Couns 2016;25:373-84
   PubMed Web of Science ®Google Scholar
• Meikle PJ, Ranieri E, Ravenscroft EM, et al. Newborn screening for lysosomal storage disorders. Southeast Asian J Trop Med Public Health 1999;30(Suppl 2):104-10
   PubMedGoogle Scholar
• Spiegel R, Raas-Rothschild A, Reish O, et al. The clinical spectrum of fetal Niemann-Pick type C. Am J Med Genet A 2009;149A:446-50
   PubMed Web of Science ®Google Scholar
• Colin E, Barth M, Boussion F, et al. In utero diagnosis of Niemann-Pick type C in the absence of family history. JIMD Rep 2015;28:105-10
   PubMedGoogle Scholar
• Mackie FL, Hemming K, Allen S, et al. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. BJOG 2017;124:32-46
   PubMed Web of Science ®Google Scholar
• Mak CM, Lee HC, Chan AY, et al. Inborn errors of metabolism and expanded newborn screening: review and update. Crit Rev Clin Lab Sci 2013;50:142-62
   PubMed Web of Science ®Google Scholar
• Jiang X, Ory DS. Towards a new diagnostic standard for Niemann-Pick C disease. EBioMedicine 2016;4:18-19
   PubMed Web of Science ®Google Scholar
• Ross LF. Newborn screening for lysosomal storage diseases: an ethical and policy analysis. J Inherit Metab Dis 2012;35:627-34
   PubMed Web of Science ®Google Scholar
• Yanjanin NM, Velez JI, Gropman A, et al. Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C. Am J Med Genet B Neuropsychiatr Genet 2010;153B:132-40
   PubMed Web of Science ®Google Scholar
• Reunert J, Fobker M, Kannenberg F, et al. Rapid diagnosis of 83 patients with Niemann Pick type C disease and related cholesterol transport disorders by cholestantriol screening. EBioMedicine 2016;4:170-5
   PubMed Web of Science ®Google Scholar